European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)

Authors/Task Force Members:, Perk, Joep, De Backer, Guy, Gohlke, Helmut, Graham, Ian, Reiner, Željko, Verschuren, Monique, Albus, Christian +80 more·2012·European Heart Journal

Cites (868)

Items 801–884 of 884

  1. Influence Of Body Fat Percentage On Agility, Strength, And Endurance Performance
    Katie J. Bouley, Mary C. Pieklo, Tracey Matthews, Vincent J. Paolone · 2009 · Medicine & Science in Sports & Exercise
  2. Volumetric intravascular ultrasound quantification of the amount of atherosclerosis and calcium in nonstenotic arterial segments
    Tinana, Adrienne, Mintz, Gary S, Weissman, Neil J · 2002 · The American Journal of Cardiology
  3. Genetic Variants Identified in a European Genome-Wide Association Study That Were Found to Predict Incident Coronary Heart Disease in the Atherosclerosis Risk in Communities Study
    Jan Bressler, A.R. Folsom, David J. Couper, Kelly A. Volcik, Eric Boerwinkle · 2009 · American Journal of Epidemiology
  4. Evidence-based medicine and treatment choices
    Stephen Frankel, George Davey Smith · 1997 · The Lancet
  5. Cardiovascular disease risk factors among five major ethnic groups in Oslo, Norway: the Oslo Immigrant Health Study
    Kathleen Glenday, Bernadette Nirmal Kumar, Aage Tverdal, Helmut E. Meyer · 2006 · European Journal of Cardiovascular Prevention & Rehabilitation
  6. Multislice computed tomography coronary angiography for risk stratification in patients with an intermediate pretest likelihood
    van Werkhoven, J M, Gaemperli, O, Schuijf, J D, Jukema, J W, Kroft, L J, Leschka, S, Alkadhi, H, Valenta, I, Pundziute, G, de Roos, A et al. · 2009 · Heart
  7. Risk Assessment for Heart Disease and Workplace ETS Exposure among Nonsmokers
    Kyle Steenland · 1999 · Environmental Health Perspectives
  8. Effectiveness of nurse-led cardiac clinics in adult patients with a diagnosis of coronary heart disease
    Tamara Page, Craig S. Lockwood, Tiffany Conroy · 2005 · International Journal of Evidence-Based Healthcare
  9. A review of family history of cardiovascular disease: risk factor and research tool
    Amitava Banerjee · 2012 · International Journal of Clinical Practice
  10. Implementation of Spanish adaptation of the European guidelines on cardiovascular disease prevention in primary care
    Carlos Brotons, José María Lobos, Miguel Ángel Royo‐Bordonada, Antonio Maiques, Ana de Santiago, Ángel Martín Castellanos, Santiago Ramirez Diaz, Juan Carlos Obaya, Juan Pedro‐Botet, Irene Moral et al. · 2013 · BMC Family Practice
  11. Left ventricular architecture and survival in African-Americans free of coronary heart disease (from the Atherosclerosis Risk in Communities [ARIC] study)
    Taylor, Herman A., Penman, Alan D., Han, Hui, Dele-Michael, Abiola, Skelton, Thomas N., Fox, Ervin R., Benjamin, Emelia J., Arnett, Donna K., Mosley, Thomas H. · 2007 · The American Journal of Cardiology
  12. Longing for clinical excellence
    Alberto Zanchetti, Giuseppe Mancia · 2012 · Journal of Hypertension
  13. Integrating Information From Novel Risk Factors With Calculated Risks
    Albertus Jozef Kooter, Pieter J. Kostense, Jan Groenewold, Abel Thijs, Naveed A. Sattar, Yvo Michiel Smulders · 2011 · Circulation
  14. Global alcohol policy and the alcohol industry
    P. Anderson · 2009 · Current Opinion in Psychiatry
  15. Cardiovascular Disease Prevention and Disease Management: A CRITICAL ROLE FOR NURSING
    Berra, K., Miller, N. Houston, Fair, J. M. · 2006 · Journal of Cardiopulmonary Rehabilitation
  16. Cost-effectiveness of a European preventive cardiology programme in primary care: a Markov modelling approach
    Mistry, Hema, Morris, Stephen, Dyer, Matthew, Kotseva, Kornelia, Wood, David, Buxton, Martin · 2012 · BMJ Open
  17. Peroxynitrite-mediated oxidative modification of low-density lipoprotein by aqueous extracts of cigarette smoke and the preventive effect of fluvastatin
    Yuji Yamaguchi · 2004 · Atherosclerosis
  18. Modelling the impact of specific food policy options on coronary heart disease and stroke deaths in Ireland
    O'Keeffe, Celine, Kabir, Zubair, O'Flaherty, Martin, Walton, Janette, Capewell, Simon, Perry, Ivan J · 2013 · BMJ Open
  19. Cardiovascular disease by diabetes status in five ethnic minority groups compared to ethnic Norwegians
    Anh Thi Tran, Jørund Straand, Lien My Diep, Helmut E. Meyer, Kåre I. Birkeland, Anne Karen Jenum · 2011 · BMC Public Health
  20. Coronary age as a risk factor in the modified Framingham risk score
    Schisterman, Enrique F, Whitcomb, Brian W · 2004 · BMC Medical Imaging
  21. Efficacy of In-Hospital Multidimensional Interventions of Secondary Prevention After Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
    Auer, Reto, Gaume, Jacques, Rodondi, Nicolas, Cornuz, Jacques, Ghali, William A. · 2008 · Circulation
  22. Nicotine receptor partial agonists for smoking cessation
    Cahill, Kate, Stead, Lindsay F, Lancaster, Tim · 2010 · Cochrane Database of Systematic Reviews
  23. Evaluation of the American Heart Association cardiovascular disease prevention guideline for women
    Hsia, Judith, Rodabough, Rebecca J., Manson, JoAnn E., Liu, Simin, Freiberg, Matthew S., Graettinger, William, Rosal, Milagros C., Cochrane, Barb, Lloyd-Jones, Donald, Robinson, Jennifer G. et al. · 2010 · Circulation: Cardiovascular Quality and Outcomes
  24. Cardiovascular Events Associated With Exercise: THE RISK-PROTECTION PARADOX
    Franklin, Barry A. · 2005 · Journal of Cardiopulmonary Rehabilitation
  25. Alcohol and Cardiovascular Mortality
    Arthur L. Klatsky · 2010 · Journal of the American College of Cardiology
  26. The Bold Promise Project: a system change in primary care to support cardiovascular risk screening.
    Gary Sinclair, Andrew Kerr · 2006 · PubMed
  27. Ethnic differences in blood pressure monitoring and control in south east London
    Peter Schofield, Ömer R. Saka, Mark J. Ashworth · 2011 · British Journal of General Practice
  28. Does surveillance impact on cardiovascular prevention?
    A. Di Chiara, Diego Vanuzzo · 2009 · European Heart Journal
  29. Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack
    Peter AG Sandercock, Orell Mielke, Ming Liu, Carl E Counsell · 2003 · Cochrane Database of Systematic Reviews
  30. Predicting cardiovascular events with coronary calcium scoring
    Weintraub, William S., Diamond, George A. · 2008 · New England Journal of Medicine
  31. Do immigrants from Turkey, Pakistan and Yugoslavia receive adequate medical treatment with beta-blockers and statins after acute myocardial infarction compared with Danish-born residents? A register-based follow-up study
    Nana Folmann Hempler, Finn Diderichsen, Finn Breinholt Larsen, Steen Ladelund, Torben Jørgensen · 2010 · European Journal of Clinical Pharmacology
  32. Incidence of acute myocardial infarction in first and second generation minority groups: Does the second generation converge towards the majority population?
    Aloysia A. M. van Oeffelen, Ilonca C. H. Vaartjes, Karien Stronks, Michiel L. Bots, Charles O Agyemang · 2013 · International Journal of Cardiology
  33. Atenolol as initial antihypertensive therapy: an observational study comparing first-line agents
    Blackburn, David F, Lamb, Darcy A, Eurich, Dean T, Johnson, Jeffrey A, Wilson, Thomas W, Dobson, Roy T, Blackburn, James L · 2007 · Journal of Hypertension
  34. Ethnic variations in the incidence and mortality of stroke in the Scottish Health and Ethnicity Linkage Study of 4.65 million people
    RS Bhopal, Narinder Bansal, Colin Fischbacher, Helen K. Brown, Simon Capewell, (on behalf of the Scottish Health and Ethnic Linkage Study) · 2011 · European Journal of Preventive Cardiology
  35. Doctors??? estimation of cardiovascular risk and willingness to give drug treatment in hypertension: fair risk assessment but defensive treatment policy
    Persson, Mats, Carlberg, Bo, Tavelin, Bj??rn, Lindholm, Lars H · 2004 · Journal of Hypertension
  36. Interventions to improve guideline compliance following coronary artery bypass grafting
    Felix K. Yam, Wendell S. Akers, Victor A. Ferraris, Kelly M. Smith, Chand Ramaiah, Phillip C. Camp, Jeremy D. Flynn · 2006 · Surgery
  37. Home based versus centre based cardiac rehabilitation: Cochrane systematic review and meta-analysis1)
    Hitarth Dalal, Anna Zawada, Kate B Jolly, Tiffany Moxham, RS Taylor, Anne Maria Eskes, Hester Vermeulen · 2010 · Nederlands Tijdschrift voor Evidence Based Practice
  38. No long-term psychological reaction to information about increased risk of coronary heart disease in general practice
    Bo Christensen, Marianne Engberg, Torsten Lauritzen · 2004 · European Journal of Cardiovascular Prevention & Rehabilitation
  39. EUROPEAN CARDIOVASCULAR DISEASE STATISTICS: THE EUROPEAN HEART HEALTH II (EUROHEART II) PROJECT
    Nick P Townsend, Melanie S. Nichols, Peter Scarborough, Marilyn Rayner · 2013 · The Cardiology
  40. Short-term outcome and attainment of secondary prevention goals in patients with acute coronary syndrome—Results from the countrywide TARGET study
    George K. Andrikopoulos, Stylianos E. Tzeis, Nikos Nikas, Dimitrios J. Richter, Athanasios G. Pipilis, A. Gotsis, Themistoklis Tsaknakis, Athanasios N. Kartalis, Anastasia N. Kitsiou, Konstantina Toli et al. · 2012 · International Journal of Cardiology
  41. Effects of different dietary fats on plasma-lipid levels
    KEYS, A · 1965 · The Lancet
  42. Physical activity in European seniors: attitudes, beliefs and levels.
    Cláudia Afonso, Pedro Graça, J. M. Kearney, M. J. Gibney, M. D. V. de Almeida · 2001 · PubMed
  43. Heterogeneity in Cause-Specific Mortality According to Birthplace in Immigrant Men Residing in Madrid, Spain
    Enrique Regidor, Luís de la Fuente, David Martı́nez, Marı́a Elisa Calle, Vicente Domı́nguez · 2008 · Annals of Epidemiology
  44. Comparison of recovery after mitral valve repair and replacement
    Liping Zhao, Paul Kolm, Michael Andrew Borger, Zefeng Zhang, Cheryl Lewis, Grant T. Anderson, Claudine T. Jurkovitz, A. Michael Borkon, Robert H. Lyles, William S. Weintraub · 2007 · Journal of Thoracic and Cardiovascular Surgery
  45. Safety of cardiac rehabilitation in a medically supervised, community-based program
    Scheinowitz, Mickey, Harpaz, David · 2005 · Cardiology
  46. How to improve cardiovascular diseases prevention in Europe?
    Željko Reiner · 2009 · Nutrition Metabolism and Cardiovascular Diseases
  47. Plant sterols in atherosclerosis prevention
    Gustav Schonfeld · 2010 · American Journal of Clinical Nutrition
  48. Changes in cardiovascular risk factors in relation to increasing ethnic inequalities in cardiovascular mortality: comparison of cross-sectional data in the Health Surveys for England 1999 and 2004
    Raj S. Bhopal, Roger W. Humphry, Colin Fischbacher · 2013 · BMJ Open
  49. The double jeopardy of clustered measurement and cluster randomisation
    Kramer, M. S, Martin, R. M, Sterne, J. A C, Shapiro, S., Dahhou, M., Platt, R. W · 2009 · BMJ
  50. The cost effectiveness of statin therapies in Spain in 2010, after the introduction of generics and reference prices
    Plans-Rubió, Pedro · 2010 · American Journal Cardiovascular Drugs
  51. Effect of including nonfatal events in cardiovascular risk estimation, illustrated with data from The Netherlands
    Ineke van Dis, Johanna Marianne Geleijnse, Jolanda M.A. Boer, Daan Kromhout, Hendriek C. Boshuizen, Diederick E. Grobbee, Yvonne T. van der Schouw, W. M. Monique Verschuren · 2012 · European Journal of Preventive Cardiology
  52. A cross-national comparative study of smoking prevalence and cessation between English and Dutch South Asian and African origin populations: the role of national context
    Charles O Agyemang, Karien Stronks, N. Tromp, R. Bhopal, Paola Zaninotto, Nigel C. Unwin, James Yzet Nazroo, Anton Eduard Kunst · 2010 · Nicotine & Tobacco Research
  53. Screening for risk of cardiovascular disease is not associated with mental distress
    Torben Jørgensen, Steen Ladelund, Knut Borch‐Johnsen, Charlotta Holm Pisinger, Anne-Marie Schrader, Troels Thomsen, Charlotte Glümer, Hans Ibsen, Erik Lykke Mortensen · 2008 · Preventive Medicine
  54. A population study of the contribution of medical comorbidity to the risk of prematurity in blacks
    Deborah B. Ehrenthal, Claudine T. Jurkovitz, Matthew Hoffman, Charlan D. Kroelinger, William S. Weintraub · 2007 · American Journal of Obstetrics and Gynecology
  55. Different Distribution of Cardiovascular Risk Factors According to Ethnicity: A Study in a High Risk Population
    Fatima El Fakiri, Marc Abraham Bruijnzeels, M. Foets, Arno Wilhelmus Hoes · 2008 · Journal of Immigrant and Minority Health
  56. Comparison of spiral and electron beam tomography in the evaluation of coronary calcification in asymptomatic persons
    Sigmund Silber · 2002 · International Journal of Cardiology
  57. CUORE: a sustainable cardiovascular disease prevention strategy
    Simona Giampaoli · 2007 · European Journal of Cardiovascular Prevention & Rehabilitation
  58. Comparison of coronary imaging between magnetic resonance imaging and electron beam computed tomography
    van Geuns, Robert-Jan M, Oudkerk, Matthijs, Rensing, Benno J.W.M, Bongaerts, Alfons H.H, de Bruin, Hein G, Wielopolski, Piotr A, van Ooijen, Peter, de Feyter, Pim J, Serruys, Patrick W · 2002 · The American Journal of Cardiology
  59. The political power of heart doctors: with the European Heart Health Charter towards a European policy on cardiovascular disease
    Sophie O’Kelly, Lars Rydén · 2009 · European Journal of Cardiovascular Prevention & Rehabilitation
  60. Global Cardiovascular Disease Prevention: A Call to Action for Nursing: The Global Burden of Cardiovascular Disease
    Berra, Kathy, Fletcher, Barbara J., Hayman, Laura L., Miller, Nancy Houston · 2011 · Journal of Cardiovascular Nursing
  61. Impact of ezetimibe on cholesterol subfractions in dyslipidemic cardiac transplant recipients receiving statin therapy
    Vy–Van Le, Normand Racine, Guy B. Pelletier, Michel Carrier, Mariève Cossette, Michel White · 2009 · Clinical Transplantation
  62. HbA1c in type 2 diabetes diagnostic criteria: addressing the right questions to move the field forwards
    Naveed A. Sattar, David Preiss · 2012 · Diabetologia
  63. Clinical Utility of Genetic Variants for Cardiovascular Risk Prediction
    Emanuele Di Angelantonio, Adam S. Butterworth · 2012 · Circulation Cardiovascular Genetics
  64. Atherosclerosis of retinal arteries in men: role of serum lipoproteins and apoproteins.
    Eugenia Tedeschi-Reiner, Željko Reiner, Zdenko Sonicki · 2004 · PubMed
  65. Estimating the value of information in strategies for identifying patients at high risk of cardiovascular disease
    Tom P Marshall · 2006 · Journal of Innovation in Health Informatics
  66. Mortalidad por enfermedades cardiovasculares en inmigrantes residentes en la Comunidad de Madrid
    Enrique Regidor, Elena Ronda, Cruz Pascual, David Martı́nez, Marı́a Elisa Calle, Vicente Domı́nguez · 2009 · Medicina Clínica
  67. Population Screening for Coronary Artery Calcification Does Not Increase Mental Distress and the Use of Psychoactive Medication
    Anders Daldorph Nielsen, Poul Videbech, Oke Gerke, Henrik Petersen, Jesper Møller Jensen, Niels Peter Rønnow Sand, Kenneth Egstrup, Mogens Lytken Larsen, Hans Mickley, Axel Cosmus Pyndt Diederichsen · 2012 · Journal of Thoracic Imaging
  68. Informed Consent for Genetic Research
    Jeffrey R. Botkin · 2010 · Current Protocols in Human Genetics
  69. Protection of patients with diabetes, with or without hypertension: implications of ADVANCE for clinical practice
    Giuseppe Mancia, Guido M. Grassi · 2009 · Journal of Hypertension
  70. The Swedish paradox: or is there really no gender difference in acute coronary syndromes?
    Helge Möllmann, Cristoph Liebetrau, HOLGER M. NEF, Christian W. Hamm · 2011 · European Heart Journal
  71. Masked Hypertension and White-Coat Hypertension Prognosis
    Willem J. Verberk, Abraham A. Kroon, Peter Wilhelmus De Leeuw · 2006 · Journal of the American College of Cardiology
  72. Evolución del riesgo cardiovascular de los inmigrantes residentes en España según procedencia y años de estancia
    María Luisa Lozano Sánchez, Mariano Leal Hernández, José Abellán Huerta, Purificación Gómez Jara, Enrique J Ortín Ortín, José Abellán Alemán · 2012 · Atención Primaria
  73. Global Cardiovascular Disease Prevention: A Call to Action for Nursing the Global Burden of Cardiovascular Disease
    Kathy A. Berra, Barbara Johnston Fletcher, Laura Lucia Hayman, Nancy Houston Miller · 2011 · European Journal of Cardiovascular Nursing
  74. Differing perspectives on preventive care guidelines: a new look at the mammography controversy
    Steven H. Woolf, Larry L. Dickey · 1999 · American Journal of Preventive Medicine
  75. [Concomitant use of statins and cytochrome P 450 inhibitors in Croatia].
    Željko Reiner, Maja Galić, Miroslav Hanževački, Eugenia Tedeschi-Reiner · 2005 · PubMed
  76. Risk assessment and management of cardiovascular disease in New Zealand.
    Michael J.A. Williams · 2003 · PubMed
  77. Varenicline raises risk of heart problems, analysis indicates
    Nigel Hawkes · 2011 · BMJ
  78. Sustainable development and the social gradient in coronary heart disease
    Michael Gideon Marmot · 2001 · European Heart Journal
  79. Tobacco images and texts in Norwegian magazines and newspapers
    Maja‐Lisa Løchen, Inger Torhild Gram, Sigrid Skattebo, Nils Kolstrup · 2006 · Scandinavian Journal of Public Health
  80. Serum Cholesterol Level and Mortality Findings for Men Screened in the Multiple Risk Factor Intervention Trial
    Neaton, James D. · 1992 · Archives of Internal Medicine
  81. Marital Stress Worsens Prognosis in Women With Coronary Heart Disease: The Stockholm Female Coronary Risk Study
    Orth-Gomér, Kristina, Wamala, Sarah P., Horsten, Myriam, Schenck-Gustafsson, Karin, Schneiderman, Neil, Mittleman, Murray A. · 2000 · JAMA
  82. Use of snus during pregnancy is not without risk
    Maja‐Lisa Løchen, Svein Høegh Henrichsen, Tom Kristian Grimsrud, Turid Lingaas Holmen, Frode Gallefoss · 2012 · Tidsskrift for Den norske legeforening
  83. Evidence-based medicine and treatment choices
    John H N Wolfe · 1997 · The Lancet
  84. Plasma Cholesterol Concentration and Mortality
    George Davey Smith · 1992 · JAMA